These Healthcare stocks are trading higher:
-Outlook Therapeutics Inc (OTLK) stock is trading at $8.76, a gain of $3.03, or 52.36%, on high volume. Outlook Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $2.18.
-P3 Health Partners Inc (PIII) stock is trading at $1.00, a rise of $0.29, or 42.92%, on high volume. P3 Health Partners Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.25. P3 Health Partners Inc next reports earnings on March 29.
-Akebia Therapeutics Inc (AKBA) stock is trading at $1.77, a gain of $0.4, or 28.5%, on high volume. Akebia Therapeutics gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $4.33.
-aTyr Pharma Inc (LIFE) stock is trading at $1.93, an increase of $0.31, or 19.44%, on moderate volume. Atyr Pharma Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $24.67.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Immuneering Corp (IMRX) stock is trading at $2.06, a loss of $0.84, or 29.31%, on high volume. Immuneering Corp Cl A gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $19.14.
-Sellas Life Sciences Group Inc (SLS) stock is trading at $1.11, a decline of $0.44, or 28.71%, on high volume. Sellas Life Sciences Group Inc gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.33. Sellas Life Sciences Group Inc next reports earnings on March 21.
-Lucy Scientific Discovery Inc (LSDI) stock is trading at $1.24, a decline of $0.44, or 26.19%, on high volume. Lucy Scientific Discovery Inc gets a Sentiment Score of Bearish from InvestorsObserver.
-Regulus Therapeutics Inc (RGLS) stock is trading at $2.11, a decline of $0.34, or 13.91%, on low volume. Regulus Therapeutics gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.50. Regulus Therapeutics next reports earnings on March 28.
Find the top stocks in the Healthcare Sector here.